Klausner Jill Q, Lawrence Peter F, Harlander-Locke Michael P, Coleman Dawn M, Stanley James C, Fujimura Naoki
Division of Vascular Surgery, University of California Los Angeles, Los Angeles, Calif.
Division of Vascular Surgery, University of California Los Angeles, Los Angeles, Calif.
J Vasc Surg. 2015 Apr;61(4):978-84. doi: 10.1016/j.jvs.2014.10.107. Epub 2014 Dec 20.
Renal artery aneurysms (RAAs) are rare, with little known about their natural history and growth rate or their optimal management. The specific objectives of this study were to (1) define the clinical features of RAAs, including the precise growth rate and risk of rupture, (2) examine the current management and outcomes of RAA treatment using existing guidelines, and (3) examine the appropriateness of current criteria for repair of asymptomatic RAAs.
A standardized, multi-institutional approach was used to evaluate patients with RAAs at institutions from all regions of the United States. Patient demographics, aneurysm characteristics, aneurysm imaging, conservative and operative management, postoperative complications, and follow-up data were collected.
A total of 865 RAAs in 760 patients were identified at 16 institutions. Of these, 75% were asymptomatic; symptomatic patients had difficult-to-control hypertension (10%), flank pain (6%), hematuria (4%), and abdominal pain (2%). The RAAs had a mean maximum diameter of 1.5 ± 0.1 cm. Most were unilateral (96%), on the right side (61%), saccular (87%), and calcified (56%). Elective repair was performed in 213 patients with 241 RAAs, usually for symptoms or size >2 cm; the remaining 547 patients with 624 RAAs were observed. Major operative complications occurred in 10%, including multisystem organ failure, myocardial infarction, and renal failure requiring dialysis. RAA repair for difficult-to-control hypertension cured 32% of patients and improved it in 26%. Three patients had ruptured RAA; all were transferred from other hospitals and underwent emergency repair, with no deaths. Conservatively treated patients were monitored for a mean of 49 months, with no acute complications. Aneurysm growth rate was 0.086 cm/y, with no difference between calcified and noncalcified aneurysms.
This large, contemporary, multi-institutional study demonstrated that asymptomatic RAAs rarely rupture (even when >2 cm), growth rate is 0.086 ± 0.08 cm/y, and calcification does not protect against enlargement. RAA open repair is associated with significant minor morbidity, but rarely a major morbidity or mortality. Aneurysm repair cured or improved hypertension in >50% of patients whose RAA was identified during the workup for difficult-to-control hypertension.
肾动脉动脉瘤(RAA)较为罕见,对其自然病史、生长速率或最佳治疗方案知之甚少。本研究的具体目标是:(1)明确RAA的临床特征,包括确切的生长速率和破裂风险;(2)依据现有指南,审视RAA治疗的当前管理方式及结果;(3)评估当前无症状RAA修复标准的适宜性。
采用标准化的多机构研究方法,对来自美国各个地区机构的RAA患者进行评估。收集患者的人口统计学资料、动脉瘤特征、动脉瘤影像学资料、保守及手术治疗情况、术后并发症以及随访数据。
在16家机构共识别出760例患者的865个RAA。其中,75%为无症状性;有症状的患者表现为难治性高血压(10%)、胁腹痛(6%)、血尿(4%)和腹痛(2%)。RAA的平均最大直径为1.5±0.1厘米。大多数为单侧(96%),位于右侧(61%),呈囊状(87%),且伴有钙化(56%)。213例患有241个RAA的患者接受了择期修复,通常是因为出现症状或动脉瘤大小>2厘米;其余547例患有624个RAA的患者接受观察。主要手术并发症发生率为10%,包括多系统器官衰竭、心肌梗死以及需要透析的肾衰竭。因难治性高血压进行的RAA修复使32%的患者治愈,26%的患者病情改善。3例患者发生RAA破裂;均从其他医院转诊并接受急诊修复,无死亡病例。接受保守治疗的患者平均监测49个月,无急性并发症。动脉瘤生长速率为每年0.086厘米,钙化动脉瘤与非钙化动脉瘤之间无差异。
这项大型、当代、多机构研究表明,无症状RAA很少破裂(即使直径>2厘米),生长速率为0.086±0.08厘米/年,钙化并不能防止动脉瘤增大。RAA开放修复与显著的轻微并发症相关,但很少出现严重并发症或死亡。在难治性高血压检查期间发现RAA的患者中,动脉瘤修复使>50%的患者高血压得到治愈或改善。